✦ LIBER ✦

739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)

✍ Scribed by Chan, H.L.; Ahn, S.H.; Chang, T.-T.; Peng, C.-Y.; Wong, D.; Coffin, C.; Lim, S.G.; Chen, P.-J.; Janssen, H.L.; Marcellin, P.; Serfaty, L.; Zeuzem, S.; Hu, W.; Critelli, L.; Wind-Rotolo, M.; Srinivasan, S.; Lopez-Talavera, J.C.; Cooney, E.

Book ID: 123246608
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 62 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60741-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O115 PEGINTERFERON LAMBDA FOR THE TREATM

O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE

✍ Chan, H.L.; Ahn, S.H.; Chang, T.-T.; Peng, C.-Y.; Wong, D.; Coffin, C.S.; Lim, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P1067 RESPONSE-GUIDED PEGINTERFERON ALFA

P1067 RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)

✍ Hou, J.; Ma, H.; Sun, J.; Xie, Q.; Xie, Y.; Sun, Y.; Wang, H.; Shi, G.; Wan, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

[488] WITHDRAWAL FLARES AFTER TREATMENT

[488] WITHDRAWAL FLARES AFTER TREATMENT WITH PEGINTERFERON ALPHA-2b ALONE OR IN COMBINATION WITH LAMIVUDINE IN HBeAg-POSITIVE CHRONIC HEPATITIS B

✍ E.H.C.J. Buster; H.J. Flink; B.E. Hansen; H.L.A. Janssen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 149 KB

HBV DNA suppression in HBeAg-positive ch

HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo

✍ Bettina E. Hansen; Vincent Rijckborst; Martijn J. ter Borg; Prof. Harry L.A. Jan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

## Abstract The aim of the present study was to compare the decline of HBV DNA during peginterferon (PEG‐IFN) therapy with spontaneous HBV DNA decline in placebo‐treated patients with hepatitis B e antigen (HBeAg)‐positive chronic hepatitis B. A total of 136 patients who participated in a randomize

Peginterferon alfa-2B and lamivudine com

Peginterferon alfa-2B and lamivudine combination therapy compared with peginterferon alfa-2B for chronic hbeag-positive hepatitis B: A randomized controlled trial in 307 patients

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

1031 DURABILITY OF PEGINTERFERON ALFA-2B

1031 DURABILITY OF PEGINTERFERON ALFA-2B TREATMENT BEYOND 5 YEARS IN PATIENTS WITH HEPATITIS B E ANTIGEN (HBEAG) POSITIVE CHRONIC HEPATITIS B

✍ Wong, V.W.-S.; Wong, G.L.-H.; Yan, K.K.-L.; Chim, A.M.-L.; Chan, H.-Y.; Chan, H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB